Bringing the fundamentals into focus…
Back to Johnson & Johnson
How Johnson & Johnson stacks up
JNJ · against 454 other Healthcare companies listed in US-listed
Growth
48/ 100
Below the middle of the pack.
Ranked #297 of 455 · scores higher than 34% of peers
Bars: peers in each 10-point band of the growth score27 peers with a growth score of 40–49, including JNJ · Click a bar to see the companies
Why growth scores 48?
Weighted metrics compared with all Healthcare companies.A mix: stronger 3-year revenue growth, but weaker earnings per share growth than most Healthcare peers.
- slower growth in earnings per share: weaker than 68% of peers. Earnings per share growth: -7.2% vs peer median 9.8%
- Revenue growth is close to the peer norm. Revenue growth: 8.1% vs peer median 6.1%
- faster revenue growth over three years: stronger than 61% of peers. 3-year revenue growth: 9.3% vs peer median 5.8%
Metric by metric
Position: dot = JNJ, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | JNJ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 8.1% | 10.8% | 43% | 33% | |
| Earnings per share growthHigher is better · 170 reported | -7.2% | 22.3% | 24% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 9.3% | 11.0% | 46% | 33% |
Ranking by growth score
Top 5 and the companies ranked around JNJ| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 551M USD | 100 | 53 | |
| 1 | 658M USD | 100 | 91 | |
| 3 | 1.4B USD | 99 | 73 | |
| 3 | 567M USD | 99 | 81 | |
| 3 | 10.3B USD | 99 | 33 | |
| 293 | 76.4B USD | 49 | 70 | |
| 297 | 47.7B USD | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score